Royal Bank of Canada
HCAT icon

Royal Bank of Canada’s Health Catalyst HCAT Stock Holding History

Royal Bank of Canada’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,305
Closed -$3K – 7361
2025
Q4 		$3K Sell
1,305
-2,794
-68% -$7.64K ﹤0.01% 6830
2025
Q3 		$12K Sell
4,099
-1,684
-29% -$5.76K ﹤0.01% 6417
2025
Q2 		$22K Sell
5,783
-160,680
-97% -$632K ﹤0.01% 6227
2025
Q1 		$754K Sell
166,463
-5,435
-3% -$28.8K ﹤0.01% 3690
2024
Q4 		$1.22M Buy
171,898
+4,810
+3% +$38.3K ﹤0.01% 3378
2024
Q3 		$1.36M Sell
167,088
-49,518
-23% -$358K ﹤0.01% 3286
2024
Q2 		$1.38M Buy
216,606
+2,802
+1% +$18K ﹤0.01% 3194
2024
Q1 		$1.61M Sell
213,804
-15,389
-7% -$140K ﹤0.01% 3095
2023
Q4 		$2.12M Sell
229,193
-69,952
-23% -$572K ﹤0.01% 3031
2023
Q3 		$3.03M Sell
299,145
-16,155
-5% -$193K ﹤0.01% 2492
2023
Q2 		$3.94M Buy
315,300
+1,564
+0.5% +$18.6K ﹤0.01% 2280
2023
Q1 		$3.66M Buy
313,736
+26,127
+9% +$333K ﹤0.01% 2325
2022
Q4 		$3.06M Sell
287,609
-44,495
-13% -$430K ﹤0.01% 2542
2022
Q3 		$3.22M Buy
332,104
+3,093
+0.9% +$41K ﹤0.01% 2446
2022
Q2 		$4.77M Sell
329,011
-122,508
-27% -$2.09M ﹤0.01% 2137
2022
Q1 		$11.8M Buy
451,519
+34,091
+8% +$967K ﹤0.01% 1602
2021
Q4 		$16.5M Buy
417,428
+140,387
+51% +$6.4M ﹤0.01% 1520
2021
Q3 		$13.9M Buy
277,041
+16,534
+6% +$902K ﹤0.01% 1596
2021
Q2 		$14.5M Buy
260,507
+2,735
+1% +$146K ﹤0.01% 1572
2021
Q1 		$12.1M Buy
257,772
+11,106
+5% +$538K ﹤0.01% 1618
2020
Q4 		$10.7M Sell
246,666
-43,109
-15% -$1.59M ﹤0.01% 1661
2020
Q3 		$10.6M Sell
289,775
-4,786
-2% -$163K ﹤0.01% 1501
2020
Q2 		$8.59M Buy
294,561
+294,471
+327,190% +$8.14M ﹤0.01% 1593
2020
Q1 		$2K Sell
90
-16,063
-99% -$491K ﹤0.01% 6294
2019
Q4 		$561K Buy
16,153
+230
+1% +$7.61K ﹤0.01% 3900
2019
Q3 		$503K Buy
+15,923
New +$627K ﹤0.01% 3840

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada's HCAT Position: Q1 2026 in Review

Royal Bank of Canada sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 1,305 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in HCAT in Q3 2019 and held it in 26 quarters. The position peaked at $16.5M in Q4 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Royal Bank of Canada reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 1,305 Health Catalyst shares in Q1 2026, an estimated $3K.
  • Royal Bank of Canada first reported a position in Health Catalyst in Q3 2019 and held it in 26 quarters.
  • Royal Bank of Canada's Health Catalyst position peaked at $16.5M in Q4 2021.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.